Targeted engagement of CTLA‐4 prevents autoimmune thyroiditis

The CTLA‐4‐mediated signal is a critical step in the down‐modulation of immune responses. The therapeutic potential of this signal to induce tissue‐specific tolerance was investigated by using an anti‐CTLA‐4 antibody that was coupled to an antibody specific for the thyrotropin receptor. After in viv...

Full description

Saved in:
Bibliographic Details
Published inInternational immunology Vol. 15; no. 5; pp. 641 - 654
Main Authors Vasu, Chenthamarakshan, Gorla, Seema R., Prabhakar, Bellur S., Holterman, Mark J.
Format Journal Article
LanguageEnglish
Published England Oxford University Press 01.05.2003
Oxford Publishing Limited (England)
Subjects
Online AccessGet full text

Cover

Loading…
Abstract The CTLA‐4‐mediated signal is a critical step in the down‐modulation of immune responses. The therapeutic potential of this signal to induce tissue‐specific tolerance was investigated by using an anti‐CTLA‐4 antibody that was coupled to an antibody specific for the thyrotropin receptor. After in vivo administration, this bispecific antibody (BiAb) accumulated in the thyroid and prevented development of experimental autoimmune thyroiditis (EAT) in mice immunized with mouse thyroglobulin (mTg). Lymphocytes from BiAb‐treated mice showed a significant reduction in their ability to proliferate, and to produce IL‐2, IFN‐γ and tumor necrosis factor (TNF)‐α, in response to mTg re‐stimulation compared to lymphocytes from untreated mice. Moreover, BiAb‐treated mice showed suppressed anti‐mTg antibody response, lymphocytic infiltration of the thyroid and follicular destruction. The BiAb targeted to the thyroid most likely facilitated engagement of CTLA‐4, resulting in an increase in the number of CD4+CD25+ T cells. These regulatory T cells suppressed in vitro mTg‐specific T cell responses, which were associated with an enhanced transforming growth factor (TGF)‐β1 production. Neutralization of TGF‐β1 increased mTg‐specific in vitro proliferation of, and IL‐2 production by, T cells from BiAb‐treated mice. Our data suggest that engagement of CTLA‐4 expressed on activated autoreactive T cells in close proximity to the thyroid can increase the number of regulatory T cells and their ability to produce TGF‐β1, with a concomitant reduction in IFN‐γ and TNF‐α, resulting in suppression of EAT.
AbstractList The CTLA-4-mediated signal is a critical step in the down-modulation of immune responses. The therapeutic potential of this signal to induce tissue-specific tolerance was investigated by using an anti-CTLA-4 antibody that was coupled to an antibody specific for the thyrotropin receptor. After in vivo administration, this bispecific antibody (BiAb) accumulated in the thyroid and prevented development of experimental autoimmune thyroiditis (EAT) in mice immunized with mouse thyroglobulin (mTg). Lymphocytes from BiAb-treated mice showed a significant reduction in their ability to proliferate, and to produce IL-2, IFN-gamma and tumor necrosis factor (TNF)-alpha, in response to mTg re-stimulation compared to lymphocytes from untreated mice. Moreover, BiAb-treated mice showed suppressed anti-mTg antibody response, lymphocytic infiltration of the thyroid and follicular destruction. The BiAb targeted to the thyroid most likely facilitated engagement of CTLA-4, resulting in an increase in the number of CD4(+)CD25(+) T cells. These regulatory T cells suppressed in vitro mTg-specific T cell responses, which were associated with an enhanced transforming growth factor (TGF)-beta1 production. Neutralization of TGF-beta1 increased mTg-specific in vitro proliferation of, and IL-2 production by, T cells from BiAb-treated mice. Our data suggest that engagement of CTLA-4 expressed on activated autoreactive T cells in close proximity to the thyroid can increase the number of regulatory T cells and their ability to produce TGF-beta1, with a concomitant reduction in IFN-gamma and TNF-alpha, resulting in suppression of EAT.
The CTLA‐4‐mediated signal is a critical step in the down‐modulation of immune responses. The therapeutic potential of this signal to induce tissue‐specific tolerance was investigated by using an anti‐CTLA‐4 antibody that was coupled to an antibody specific for the thyrotropin receptor. After in vivo administration, this bispecific antibody (BiAb) accumulated in the thyroid and prevented development of experimental autoimmune thyroiditis (EAT) in mice immunized with mouse thyroglobulin (mTg). Lymphocytes from BiAb‐treated mice showed a significant reduction in their ability to proliferate, and to produce IL‐2, IFN‐γ and tumor necrosis factor (TNF)‐α, in response to mTg re‐stimulation compared to lymphocytes from untreated mice. Moreover, BiAb‐treated mice showed suppressed anti‐mTg antibody response, lymphocytic infiltration of the thyroid and follicular destruction. The BiAb targeted to the thyroid most likely facilitated engagement of CTLA‐4, resulting in an increase in the number of CD4+CD25+ T cells. These regulatory T cells suppressed in vitro mTg‐specific T cell responses, which were associated with an enhanced transforming growth factor (TGF)‐β1 production. Neutralization of TGF‐β1 increased mTg‐specific in vitro proliferation of, and IL‐2 production by, T cells from BiAb‐treated mice. Our data suggest that engagement of CTLA‐4 expressed on activated autoreactive T cells in close proximity to the thyroid can increase the number of regulatory T cells and their ability to produce TGF‐β1, with a concomitant reduction in IFN‐γ and TNF‐α, resulting in suppression of EAT.
The CTLA-4-mediated signal is a critical step in the down-modulation of immune responses. The therapeutic potential of this signal to induce tissue-specific tolerance was investigated by using an anti-CTLA-4 antibody that was coupled to an antibody specific for the thyrotropin receptor. After in vivo administration, this bispecific antibody (BiAb) accumulated in the thyroid and prevented development of experimental autoimmune thyroiditis (EAT) in mice immunized with mouse thyroglobulin (mTg). Lymphocytes from BiAb-treated mice showed a significant reduction in their ability to proliferate, and to produce IL-2, IFN-[gamma] and tumor necrosis factor (TNF)-[alpha], in response to mTg re-stimulation compared to lymphocytes from untreated mice. Moreover, BiAb-treated mice showed suppressed anti-mTg antibody response, lymphocytic infiltration of the thyroid and follicular destruction. The BiAb targeted to the thyroid most likely facilitated engagement of CTLA-4, resulting in an increase in the number of CD4+CD25+ T cells. These regulatory T cells suppressed in vitro mTg-specific T cell responses, which were associated with an enhanced transforming growth factor (TGF)-[beta]1 production. Neutralization of TGF-[beta]1 increased mTg-specific in vitro proliferation of, and IL-2 production by, T cells from BiAb-treated mice. Our data suggest that engagement of CTLA-4 expressed on activated autoreactive T cells in close proximity to the thyroid can increase the number of regulatory T cells and their ability to produce TGF-[beta]1, with a concomitant reduction in IFN-[gamma] and TNF-[alpha], resulting in suppression of EAT.
The CTLA-4-mediated signal is a critical step in the down-modulation of immune responses. The therapeutic potential of this signal to induce tissue- specific tolerance was investigated by using an anti-CTLA-4 antibody that was coupled to an antibody specific for the thyrotropin receptor. After in vivo administration, this bispecific antibody (BiAb) accumulated in the thyroid and prevented development of experimental autoimmune thyroiditis (EAT) in mice immunized with mouse thyroglobulin (mTg). Lymphocytes from BiAb-treated mice showed a significant reduction in their ability to proliferate, and to produce IL-2, IFN- gamma and tumor necrosis factor (TNF)- alpha , in response to mTg re-stimulation compared to lymphocytes from untreated mice. Moreover, BiAb- treated mice showed suppressed anti-mTg antibody response, lymphocytic infiltration of the thyroid and follicular destruction. The BiAb targeted to the thyroid most likely facilitated engagement of CTLA-4, resulting in an increase in the number of CD4 super(+)CD25 super(+) T cells. These regulatory T cells suppressed in vitro mTg-specific T cell responses, which were associated with an enhanced transforming growth factor (TGF)- beta 1 production. Neutralization of TGF- beta 1 increased mTg-specific in vitro proliferation of, and IL-2 production by, T cells from BiAb-treated mice. Our data suggest that engagement of CTLA-4 expressed on activated autoreactive T cells in close proximity to the thyroid can increase the number of regulatory T cells and their ability to produce TGF- beta 1, with a concomitant reduction in IFN- gamma and TNF- alpha , resulting in suppression of EAT.
Author Holterman, Mark J.
Gorla, Seema R.
Vasu, Chenthamarakshan
Prabhakar, Bellur S.
Author_xml – sequence: 1
  givenname: Chenthamarakshan
  surname: Vasu
  fullname: Vasu, Chenthamarakshan
  organization: Department of Surgery and
– sequence: 2
  givenname: Seema R.
  surname: Gorla
  fullname: Gorla, Seema R.
  organization: Department of Surgery and
– sequence: 3
  givenname: Bellur S.
  surname: Prabhakar
  fullname: Prabhakar, Bellur S.
  organization: Department of Microbiology and Immunology, University of Illinois at Chicago, Chicago, IL 60612, USA
– sequence: 4
  givenname: Mark J.
  surname: Holterman
  fullname: Holterman, Mark J.
  organization: Department of Surgery and
BackLink https://www.ncbi.nlm.nih.gov/pubmed/12697664$$D View this record in MEDLINE/PubMed
BookMark eNqF0MtKAzEUBuAgFa2XpVsZXLgbTSa3ZiW1eMOCCyuIm5DpnNSpnZmaZKTufASf0Scx0mLBjatA8vGfk38HdeqmBoQOCD4hWNHTsg5lVZ0WiwkWZAN1CRM4zaiUHdTFitO0R2RvG-14P8UY00zRLbRNMqGkEKyLzkbGTSBAkUA9MROooA5JY5PBaNj_-vhkydzBW7zziWlDEye1NSTh-d01ZVGG0u-hTWtmHvZX5y56uLwYDa7T4d3VzaA_TMeM05BSDsQoTmie5TKP20kBGTFAc8alVYxAUWSMUNtj2GIrDFE5JkoUFgtmeU530fEyd-6a1xZ80FXpxzCbmRqa1mtJicoUE__CyDIiKY_w6A-cNq2r4yei4ZhyjnsRpUs0do33Dqyeu7Iy7l0TrH_618v-9bL_6A9XoW1eQbHWq8LXgaUPsPh9N-5FC0kl19ePT1pc4vvb8xHXj_QbAbKTVA
CitedBy_id crossref_primary_10_1189_jlb_0803394
crossref_primary_10_3389_fimmu_2024_1387975
crossref_primary_10_1038_nbt1345
crossref_primary_10_1016_j_molmed_2004_01_009
crossref_primary_10_1210_en_2008_1389
crossref_primary_10_1080_08916930310001603073
crossref_primary_10_1210_jc_2005_2337
crossref_primary_10_1586_1744666X_3_2_217
crossref_primary_10_1186_1471_2431_13_123
crossref_primary_10_4049_jimmunol_173_4_2866
crossref_primary_10_4049_jimmunol_170_11_5511
crossref_primary_10_4049_jimmunol_0903130
crossref_primary_10_1038_s41388_022_02209_w
crossref_primary_10_1016_j_jneuroim_2003_12_003
crossref_primary_10_4049_jimmunol_179_8_5191
crossref_primary_10_1111_imm_13476
crossref_primary_10_4196_kjpp_2012_16_5_349
crossref_primary_10_1016_j_ddtec_2021_08_006
crossref_primary_10_4161_mabs_26390
crossref_primary_10_4049_jimmunol_180_10_6566
crossref_primary_10_1089_thy_2007_0406
crossref_primary_10_3389_fimmu_2023_1198365
crossref_primary_10_1021_jacs_2c00129
crossref_primary_10_1016_j_ymthe_2006_03_021
crossref_primary_10_1038_s41598_019_48464_y
crossref_primary_10_1016_j_ejim_2012_07_007
crossref_primary_10_1097_01_mot_0000130144_06730_ea
crossref_primary_10_1016_j_clim_2014_04_014
crossref_primary_10_1016_j_jaut_2009_03_010
crossref_primary_10_1016_j_jaut_2009_09_004
ContentType Journal Article
Copyright Copyright Oxford University Press(England) May 2003
Copyright_xml – notice: Copyright Oxford University Press(England) May 2003
DBID BSCLL
CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
CITATION
7QL
7QP
7QR
7T5
7T7
7TK
7U9
8FD
C1K
FR3
H94
K9.
M7N
P64
7X8
DOI 10.1093/intimm/dxg061
DatabaseName Istex
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
CrossRef
Bacteriology Abstracts (Microbiology B)
Calcium & Calcified Tissue Abstracts
Chemoreception Abstracts
Immunology Abstracts
Industrial and Applied Microbiology Abstracts (Microbiology A)
Neurosciences Abstracts
Virology and AIDS Abstracts
Technology Research Database
Environmental Sciences and Pollution Management
Engineering Research Database
AIDS and Cancer Research Abstracts
ProQuest Health & Medical Complete (Alumni)
Algology Mycology and Protozoology Abstracts (Microbiology C)
Biotechnology and BioEngineering Abstracts
MEDLINE - Academic
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
CrossRef
Virology and AIDS Abstracts
Technology Research Database
ProQuest Health & Medical Complete (Alumni)
Neurosciences Abstracts
Biotechnology and BioEngineering Abstracts
Environmental Sciences and Pollution Management
Bacteriology Abstracts (Microbiology B)
Algology Mycology and Protozoology Abstracts (Microbiology C)
AIDS and Cancer Research Abstracts
Chemoreception Abstracts
Immunology Abstracts
Engineering Research Database
Industrial and Applied Microbiology Abstracts (Microbiology A)
Calcium & Calcified Tissue Abstracts
MEDLINE - Academic
DatabaseTitleList MEDLINE - Academic

Virology and AIDS Abstracts
MEDLINE
AIDS and Cancer Research Abstracts
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Biology
EISSN 1460-2377
EndPage 654
ExternalDocumentID 345531061
10_1093_intimm_dxg061
12697664
ark_67375_HXZ_6F0SKBT5_X
Genre Research Support, Non-U.S. Gov't
Research Support, U.S. Gov't, P.H.S
Journal Article
GrantInformation_xml – fundername: NIAID NIH HHS
  grantid: K08 AI01821-01A2
GroupedDBID ---
-E4
.2P
.55
.GJ
.I3
.ZR
0R~
18M
1TH
29J
2WC
4.4
482
48X
53G
5GY
5RE
5VS
5WA
5WD
6.Y
70D
A8Z
AABZA
AACZT
AAIMJ
AAJKP
AAJQQ
AAMDB
AAMVS
AAOGV
AAPGJ
AAPNW
AAPQZ
AAPXW
AARHZ
AAUAY
AAUQX
AAVAP
AAVLN
AAWDT
ABEJV
ABEUO
ABIXL
ABJNI
ABKDP
ABMNT
ABNHQ
ABNKS
ABOCM
ABPTD
ABQLI
ABQNK
ABQTQ
ABSAR
ABSMQ
ABWST
ABXVV
ABZBJ
ACFRR
ACGFO
ACGFS
ACIWK
ACMRT
ACPQN
ACPRK
ACUFI
ACUTJ
ACUTO
ACYHN
ACZBC
ADBBV
ADEYI
ADEZT
ADFTL
ADGKP
ADGZP
ADHKW
ADHZD
ADIPN
ADJQC
ADOCK
ADQBN
ADRIX
ADRTK
ADVEK
ADYVW
ADZTZ
ADZXQ
AEGPL
AEGXH
AEHUL
AEJOX
AEKPW
AEKSI
AELWJ
AEMDU
AENEX
AENZO
AEPUE
AETBJ
AEWNT
AFFNX
AFFZL
AFGWE
AFIYH
AFOFC
AFRAH
AFSHK
AFXAL
AFXEN
AFYAG
AGINJ
AGKEF
AGKRT
AGMDO
AGQXC
AGSYK
AGUTN
AHMBA
AHXPO
AI.
AIAGR
AIJHB
AJEEA
AKHUL
AKWXX
ALMA_UNASSIGNED_HOLDINGS
ALUQC
ANFBD
APIBT
APJGH
APWMN
AQDSO
AQKUS
ARIXL
ASAOO
ASPBG
ATDFG
ATGXG
ATTQO
AVNTJ
AVWKF
AXUDD
AYOIW
AZFZN
BAWUL
BAYMD
BCRHZ
BEYMZ
BHONS
BQDIO
BSCLL
BSWAC
BTRTY
BVRKM
BZKNY
C1A
C45
CAG
CDBKE
COF
CS3
CXTWN
CZ4
DAKXR
DFGAJ
DIK
DILTD
DU5
D~K
E3Z
EBD
EBS
EE~
EIHJH
EJD
ELUNK
EMOBN
ENERS
ESTFP
F5P
F9B
FECEO
FEDTE
FHSFR
FLUFQ
FOEOM
FOTVD
FQBLK
FRP
GAUVT
GJXCC
GX1
H13
H5~
HAR
HVGLF
HW0
HZ~
IH2
IOX
J21
J8S
JXSIZ
KAQDR
KBUDW
KOP
KQ8
KSI
KSN
M-Z
M49
MBLQV
MBTAY
MHKGH
N9A
NGC
NLBLG
NOMLY
NOYVH
NTWIH
NU-
NVLIB
O0~
O9-
OAUYM
OAWHX
OBC
OBOKY
OBS
OCZFY
ODMLO
OEB
OJQWA
OJZSN
OK1
OPAEJ
OVD
OWPYF
O~Y
P2P
PAFKI
PB-
PEELM
PQQKQ
Q1.
Q5Y
QBD
R44
RD5
RIG
RNI
ROL
ROX
ROZ
RUSNO
RW1
RXO
RZF
RZO
SV3
TCN
TEORI
TJX
TLC
TMA
TR2
UDS
VH1
W8F
WOQ
X7H
X7M
Y6R
YAYTL
YHZ
YKOAZ
YXANX
ZKX
~91
CGR
CUY
CVF
ECM
EIF
NPM
AASNB
AAYXX
CITATION
7QL
7QP
7QR
7T5
7T7
7TK
7U9
8FD
C1K
FR3
H94
K9.
M7N
P64
7X8
ID FETCH-LOGICAL-c453t-35e1a9513b2b7b37776e21ae3b457f941edd2413f840f0f6a19b0196df064f5b3
ISSN 0953-8178
1460-2377
IngestDate Fri Oct 25 06:51:05 EDT 2024
Sat Oct 26 01:44:05 EDT 2024
Wed Nov 06 08:26:01 EST 2024
Thu Sep 12 20:00:41 EDT 2024
Wed Oct 16 00:51:16 EDT 2024
Wed Oct 30 09:52:56 EDT 2024
IsDoiOpenAccess false
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 5
Language English
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c453t-35e1a9513b2b7b37776e21ae3b457f941edd2413f840f0f6a19b0196df064f5b3
Notes local:dxg061
istex:B26988A79D5369C2414BF203B2C91C2D83999FC5
ark:/67375/HXZ-6F0SKBT5-X
Correspondence to: M. J. Holterman; E‐mail: rmasjet@uic.edu
 Transmitting editor: E. R. Unanue
ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-1
content type line 23
ObjectType-Article-1
ObjectType-Feature-2
OpenAccessLink https://academic.oup.com/intimm/article-pdf/15/5/641/1860601/dxg061.pdf
PMID 12697664
PQID 195035508
PQPubID 34171
PageCount 14
ParticipantIDs proquest_miscellaneous_73192946
proquest_miscellaneous_19221735
proquest_journals_195035508
crossref_primary_10_1093_intimm_dxg061
pubmed_primary_12697664
istex_primary_ark_67375_HXZ_6F0SKBT5_X
PublicationCentury 2000
PublicationDate 2003-05
2003-May
2003-5-1
20030501
PublicationDateYYYYMMDD 2003-05-01
PublicationDate_xml – month: 05
  year: 2003
  text: 2003-05
PublicationDecade 2000
PublicationPlace England
PublicationPlace_xml – name: England
– name: Oxford
PublicationTitle International immunology
PublicationTitleAlternate Int. Immunol
PublicationYear 2003
Publisher Oxford University Press
Oxford Publishing Limited (England)
Publisher_xml – name: Oxford University Press
– name: Oxford Publishing Limited (England)
SSID ssj0003293
Score 1.9249142
Snippet The CTLA‐4‐mediated signal is a critical step in the down‐modulation of immune responses. The therapeutic potential of this signal to induce tissue‐specific...
The CTLA-4-mediated signal is a critical step in the down-modulation of immune responses. The therapeutic potential of this signal to induce tissue-specific...
The CTLA-4-mediated signal is a critical step in the down-modulation of immune responses. The therapeutic potential of this signal to induce tissue- specific...
SourceID proquest
crossref
pubmed
istex
SourceType Aggregation Database
Index Database
Publisher
StartPage 641
SubjectTerms anergy
Animals
Antibodies, Bispecific - blood
Antibodies, Bispecific - immunology
Antigens, CD
Antigens, Differentiation - immunology
autoimmunity
co‐stimulation
CTLA-4 Antigen
Female
immune suppression
Interleukin-10 - metabolism
Mice
Mice, Inbred CBA
Serum - immunology
Signal Transduction - immunology
T lymphocyte
Thymus Gland - immunology
Thyroid Gland - immunology
Thyroiditis, Autoimmune - immunology
Thyroiditis, Autoimmune - metabolism
Thyroiditis, Autoimmune - prevention & control
tolerance
Transforming Growth Factor beta - metabolism
Title Targeted engagement of CTLA‐4 prevents autoimmune thyroiditis
URI https://api.istex.fr/ark:/67375/HXZ-6F0SKBT5-X/fulltext.pdf
https://www.ncbi.nlm.nih.gov/pubmed/12697664
https://www.proquest.com/docview/195035508
https://search.proquest.com/docview/19221735
https://search.proquest.com/docview/73192946
Volume 15
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1bb9MwFLZgE4gXBANGGZc8IN7CkviS5HGgdRV0A2kpinixnMZZq20JShO08es5tpO4FUxcXqIocZ3U58vx53MzQq8lkTiieeF680y4JAipG0sZuTQmBG4pX6dKTj4-YZMZ-ZDS1O6xqbNLmuzt_Mdv80r-R6pwDeSqsmT_QbJDp3ABzkG-cAQJw_HvZKzDuIEyyvKsC2LR4RXJ9MAlKv3_u85fE21TLVUeiASaeV1Xy1wVMlqnpZt2Qd12w9z-Raxa45yHDhfiUtTifLWwwDqq6gvNQk-lvBQ2CPFzLbKFODdB3CoVqK2trXVSXeh5oexzhjoXVW-DWIv4G4yJ2I18sxnPoFfpGn7ompJkptRVN98yU0T6F1Vuylwtywb-NJzkV2ce8-2s1XvqTz7x8Ww65clhmtxG2wHoG6XojlIb6YMDU3u5f8mu1Co8YN90v28636Am2-oru7p53aH5R_IA3e8WDs6BQcFDdEuWO-iO2Ur0egfdPe6CJB6hARaOhYVTFY6BhdPDwrGwcNZg8RjNxofJ-4nb7ZLhzgnFjYup9AXwZJwFWZjhMAyZDHwhcUZoWMTEl3munKcFLOULr2DCjzNVFCkvgI0WNMNP0FZZlfIpchQ3oSJgspCCCBaJWDFSYNTCw0UYRSP0ph8g_s0UQ-EmiAFzM5LcjCQ01MM3tAIMqQjCkPJJ-pWzsXf68V1CeTpCe_348u7DWnG1MzHQYA-e92q4C1pPubJEKatWNQlgLY3pzS1CmFuCmLAR2jVis28cMODgjDz742_30D2L9udoq6lb-QI4aJO91Aj7CQAdimE
link.rule.ids 315,783,787,27936,27937
linkProvider Geneva Foundation for Medical Education and Research
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Targeted+engagement+of+CTLA-4+prevents+autoimmune+thyroiditis&rft.jtitle=International+immunology&rft.au=Vasu%2C+Chenthamarakshan&rft.au=Gorla%2C+Seema+R&rft.au=Prabhakar%2C+Bellur+S&rft.au=Holterman%2C+Mark+J&rft.date=2003-05-01&rft.issn=0953-8178&rft.volume=15&rft.issue=5&rft.spage=641&rft.epage=654&rft_id=info:doi/10.1093%2Fintimm%2Fdxg061&rft.externalDBID=NO_FULL_TEXT
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0953-8178&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0953-8178&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0953-8178&client=summon